Introduction
M. Loebinger (London, United Kingdom), P. Goeminne (Bornem, Belgium)
|  |
Late Breaking Abstract - Bronchiectasis in AATD: initial report of EARCO
R. Stockley (Birmingham (West Midlands), United Kingdom), A. Pye (Birmingham (West Midlands), United Kingdom), A. Turner (Birmingham (West Midlands), United Kingdom)
|    |
The ROSE criteria for coexistent COPD-bronchiectasis: association with future exacerbations and death
W. Dolliver (Boston, MA, United States), W. Wang (Boston, MA, United States), J. Orejas (Boston, MA, United States), D. Maselli (San Antonio, TX, United States), A. Yen (San Diego, CA, United States), K. Young (Aurora, CO, United States), G. Kinney (Aurora, CO, United States), M. Cho (Boston, MA, United States), R. San José Estépar, (Boston, MA, United States), A. Diaz (Boston, MA, United States)
| |
Longitudinal analysis of bronchiectasis exacerbations (BEx) in patients from the US Bronchiectasis and NTM Research Registry (BRR)
T. Aksamit (Rochester, United States), N. Lapinel (New Orleans, United States), R. Choate (Lexington, United States), J. Feliciano (Bridgewater, United States), K. Winthrop (Portland, United States), A. Schmid (Kansas City, United States), J. Wu (Bridgewater, United States), M. Hassan (Bridgewater, United States), S. Fucile (Bridgewater, United States), M. Metersky (Farmington, United States)
| |
Dysregulation of the microbial 'gut-lung' axis in bronchiectasis
J. Narayana (Singapore, Singapore), S. Aliberti (Milan, Italy), M. Mac Aogáin (Dublin, Ireland), T. Jaggi (Singapore, Singapore), N. Ali (Singapore, Singapore), I. Fransiskus Xaverius (Singapore, Singapore), F. Amati (Milan, Italy), A. Gramegna (Milan, Italy), K. Tsaneva-Atanasova (Exeter, United Kingdom), F. Blasi (Milan, Italy), S. Chotirmall (Singapore, Singapore)
| |
Implementing tablet-based ototoxicity screening in adult respiratory patients
J. Cheong (London, United Kingdom), S. Boreland (London, United Kingdom), B. Belkarty (London, United Kingdom), A. Jones (London, United Kingdom), I. Felton (London, United Kingdom), E. Ukor (London, United Kingdom), J. Stowell (London, United Kingdom), R. Jose (London, United Kingdom), S. Madge (London, United Kingdom), J. Wilkins (London, United Kingdom), E. Frost (London, United Kingdom), P. Premachandra (London, United Kingdom), M. Loebinger (London, United Kingdom), F. Drobniewski (London, United Kingdom), N. Simmonds (London, United Kingdom), A. Shah (London, United Kingdom)
| |
Genome sequencing reveals underdiagnosis of primary ciliary dyskinesia in bronchiectasis
A. Shoemark (Dundee (Angus), United Kingdom), H. Griffin (Newcastle, United Kingdom), G. Wheway (Southampton, United Kingdom), C. Hogg (London, United Kingdom), J. Lucas (Southampton, United Kingdom), C. Camps (Oxford, United Kingdom), J. Taylor (Oxford, United Kingdom), M. Carroll (Southampton, United Kingdom), M. Loebinger (London, United Kingdom), J. Chalmers (Dundee, United Kingdom), . Morris-Rosendahl (London, United Kingdom), H. Mitchison (London, United Kingdom), A. De Soyza (Newcastle, United Kingdom)
| |
Neisseria species as pathobionts in bronchiectasis.
L. Li (Shenzhen, China), M. Mac Aogáin (Singapore, Singapore), T. Xu (Singapore, Singapore), T. Jaggi (Singapore, Singapore), L. L Y Chan (Singapore, Singapore), J. Qu (Shenzhen, China), L. Wei (Shenzhen, China), S. Liao (Shenzhen, China), H. Sheng Cheng (Singapore, Singapore), H. R Keir (Dundee, Scotland, United Kingdom), A. J Dicker (Dundee, Scotland, United Kingdom), K. Sen Tan (Singapore, Singapore), W. De Yun (Singapore, Singapore), M. Siyue Koh (Singapore, Singapore), O. Thun How (Singapore, Singapore), A. Lim Yick Hou (Singapore, Singapore), J. Arputhan Abisheganaden (Singapore, Singapore), T. Boon Low (Singapore, Singapore), T. Maharani Hassan (Kuala Lumpur, Malaysia), X. Long (Shenzhen, China), P. A.B. Wark (NSW, Australia), B. G. Oliver (Sydney, NSW, Australia), D. I Drautz-Moses (Singapore, Singapore), S. C. Schuster (Singapore, Singapore), N. Soon Tan (Singapore, Singapore), M. Fang (Singapore, Singapore), J. D Chalmers (Dundee, Scotland, United Kingdom), S. H. Chotirmall (Singapore, Singapore)
| |
Characteristics of frequent exacerbators in the US Bronchiectasis and NTM Research Registry (BRR)
N. Lapinel (New Orleans, United States), R. Choate (Lexington, United States), T. Aksamit (Rochester, United States), J. Feliciano (Bridgewater, United States), K. Winthrop (Portland, United States), A. Schmid (Kanas City, United States), J. Wu (Bridgewater, United States), M. Hassan (Bridgewater, United States), S. Fucile (Bridgewater, United States), M. Metersky (Farmington, United States)
| |
The role of the NLRP3 inflammasome in mucociliary clearance in bronchiectasis: The EMBARC-BRIDGE study
L. Perea Soriano (Dundee, United Kingdom), M. Bottier (Dundee, United Kingdom), E. Cant (Dundee, United Kingdom), H. Richardson (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), M. Shuttleworth (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), Y. Giam (Dundee, United Kingdom), S. Finch (Dundee, United Kingdom), J. Huang (Dundee, United Kingdom), M. Shteinberg (Haifa, Israel), P. Goeminne (Sint-Niklaas, Belgium), E. Polverino (Barcelona, Spain), J. Altenburg (Amsterdam, Netherlands), F. Blasi (Milano, Italy), T. Welte (Hannover, Germany), S. Aliberti (Milano, Italy), O. Sibila (Barcelona, Spain), J. Chalmers (Dundee, United Kingdom), A. Shoemark (Dundee, United Kingdom)
| |
The antimicrobial resistome in bronchiectasis: an international multicentre study
M. Mac Aogáin (Singapore, Singapore), F. Xaverius Ivan (Singapore, Singapore), T. Jaggi (Singapore, Singapore), H. R. Keir (Dundee, Scotland, United Kingdom), A. J. Dicker (Dundee, Scotland, United Kingdom), A. Lim Yick Hou (Singapore, Singapore), M. Ern Poh (Kuala Lumpur, Malaysia), M. Siyue Koh (Singapore, Singapore), O. Thun How (Singapore, Singapore), A. Tee (Singapore, Singapore), T. Boon Low (Singapore, Singapore), J. Arputhan Abisheganaden (Singapore, Singapore), F. Blasi (Milan, Italy), S. Aliberti (Milan, Italy), J. D. Chalmers (Dundee, Scotland, United Kingdom), S. H. Chotirmall (Singapore, Singapore)
| |
Discussion and Q&A
| |
What we need to build a multidisciplinary team for the optimal management of bronchiectasis
S. Aliberti (Milano (MI), Italy)
| |
How technological innovation can support physicians regarding decision making in bronchiectasis
H. Tiddens (Rotterdam, Netherlands)
| |
Bronchiectasis: is airways inflammation more important to tag than infections?
J. Chalmers (Dundee (Angus), United Kingdom)
| |
The role of microbiome analysis in the pathophysiology and clinical management of bronchiectasis
S. Chotirmall (Singapore, Singapore)
| |
Precision medicine for bronchiectasis
E. Polverino (Barcelona, Spain)
| |
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
A. Chang (Brisbane (QLD), Australia)
| |
European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis
A. Chang, R. Fortescue, K. Grimwood et al.
European Respiratory Journal 2021; DOI: 10.1183/13993003.02990-2020 |   |
Wrap-up by discussant and discussion
G. Rohde (Frankfurt am Main, Germany)
| |
RCT Abstract - An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19
B. Connolly (Belfast, United Kingdom), G. Perkins (Coventry, United Kingdom), C. Ji (Coventry, United Kingdom), K. Couper (Coventry, United Kingdom), R. Lall (Coventry, United Kingdom), J. Baillie (Midlothian, United Kingdom), J. Bradley (Belfast, United Kingdom), P. Dark (Manchester, United Kingdom), C. Dave (Birmingham, United Kingdom), A. De Soyza (Newcastle Upon Tyne, United Kingdom), A. Dennis (Birmingham, United Kingdom), A. Devrell (Coventry, United Kingdom), S. Fairbairn (Cwmbran, United Kingdom), H. Ghani (Watford, United Kingdom), E. Gorman (Belfast, United Kingdom), C. Green (Birmingham, United Kingdom), N. Hart (London, United Kingdom), S. Hee (Coventry, United Kingdom), Z. Kimbley (Birmingham, United Kingdom), S. Madathil (Birmingham, United Kingdom), N. Mcgowan (Coventry, United Kingdom), B. Messer (Newcastle Upon Tyne, United Kingdom), J. Naisbitt (Bury, United Kingdom), C. Norman (Coventry, United Kingdom), D. Parekh (Birmingham, United Kingdom), E. Parkin (Bury, United Kingdom), J. Patel (Birmingham, United Kingdom), S. Regan (Coventry, United Kingdom), C. Ross (Sunderland, United Kingdom), A. Rostron (Sunderland, United Kingdom), M. Saim (Birmingham, United Kingdom), A. Simonds (London, United Kingdom), E. Skilton (Coventry, United Kingdom), N. Stallard (Coventry, United Kingdom), M. Steiner (Leicester, United Kingdom), R. Vancheeswaran (Watford, United Kingdom), J. Yeung (Coventry, United Kingdom), D. Mc Auley (Belfast, United Kingdom), On Behalf Of The Recovery-Rs Collaborators
| |
Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial
S. Ramakrishnan (Oxford, United Kingdom), D. Nicolau Jr (Oxford, United Kingdom), B. Langford (Oxford, United Kingdom), M. Mahdi (Oxford, United Kingdom), H. Jeffers (Oxford, United Kingdom), C. Mwasuku (Oxford, United Kingdom), K. Krassowska (Oxford, United Kingdom), R. Fox (Bicester, United Kingdom), I. Binnian (Eynsham, United Kingdom), V. Glover (Faringdon, United Kingdom), S. Bright (Witney, United Kingdom), C. Butler (Oxford, United Kingdom), J. Cane (Oxford, United Kingdom), A. Halner (Oxford, United Kingdom), P. Matthews (Oxford, United Kingdom), L. Donnelly (London, United Kingdom), J. Simpson (Newcastle, New South Wales, Australia), J. Baker (London, United Kingdom), N. Fadai (Nottingham, United Kingdom), S. Peterson (Lund, Sweden), T. Bengtsson (Lund, Sweden), P. Barnes (London, United Kingdom), R. Russell (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom)
| |
Wrap-up by discussant and discussion
H. Keir (Dundee (Angus), United Kingdom)
| |
Exposure-response relationships of brensocatib in patients with non-cystic fibrosis bronchiectasis (NCFBE)
C. Fernandez (Bridgewater, United States of America), C. Rubino (Schenectady, United States of America), A. Teper (Bridgewater, United States of America), H. Usansky (Bridgewater, United States of America), J. Chalmers (Dundee, United Kingdom), K. Mange (Bridgewater, United States of America)
| |
RCT Abstract - The efficacy and safety of colistimethate sodium delivered via the I-neb in bronchiectasis: the PROMIS-I randomized controlled trial
C. Haworth (Cambridge, United Kingdom), M. Shteinberg (Haifa, Israel), K. Winthrop (Portland, United States of America), F. Blasi (Milan, Italy), K. Dimakou (Athens, Greece), L. Morgan (Sydney, Australia), F. Ringshausen (Hannover, Germany), O. Vidal (Barcelona, Spain), R. Thompson (Brisbane, Australia), K. Sharp (Farnborough, United Kingdom), I. Vissers (Bresso, Italy), D. Hull (Chichester (West Sussex), United Kingdom), J. Chalmers (Dundee, United Kingdom)
| |
Is there an association between tracheomalacia and bronchiectasis in children?
R. Thomas (Brisbane, Australia), A. Chang (Brisbane, Australia), I. Masters (Brisbane, Australia), K. Grimwood (Gold Coast, Australia), J. Marchant (Brisbane, Australia), S. Yerkovich (Brisbane, Australia), M. Chatfield (Brisbane, Australia), C. O'Brien (Brisbane, Australia), V. Goyal (Brisbane, Australia)
| |
Pulmonary vascular pruning is associated with radiographic bronchiectasis progression
W. Dolliver (Boston, United States of America), W. Wang (Boston, United States of America), P. Nardelli (Boston, United States of America), F. Rahaghi (Boston, United States of America), D. Maselli (San Antonio, United States of America), A. Yen (San Diego, United States of America), K. Young (Aurora, United States of America), G. Kinney (Aurora, United States of America), R. San José Estépar (Boston, United States of America), A. Diaz (Boston, United States of America)
| |
The Cournand Lecture: the renaissance of bronchiectasis
J. Chalmers (Dundee (Angus), United Kingdom)
| |
Discussion
| |
LSC - 2021 - Functional profiling and visualization of stromal cell dynamics in the influenza virus infected lung
W. Julie, G. Finney (g.finney.1@research.gla.ac.uk / University of Glasgow,Glasgow), C. Hansell (chahansell@gmail.com / University of Glasgow,Glasgow), J. Singh-Nijjar (jsn33@cam.ac.uk / University of Cambridge,Cambridge), F. Morton (fraser.morton@glasgow.ac.uk / University of Glasgow,Glasgow), J. Cole (john.cole@glasgow.ac.uk / University of Glasgow,Glasgow), M. Macleod (megan.macleod@glasgow.ac.uk / University of Glasgow,Glasgow)
| |
External assessment and validation of the RAPID score using an international multicentre pleural infection cohort treated with intrapleural fibrinolytics
E. Bedawi (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom), L. Yarmus (Maryland, United States of America), J. Akulian (North Carolina , United States of America)
| |
Serum heparan sulfate levels predict the etiology of acute exacerbations in COPD
E. Papakonstantinou (Basel, Switzerland), M. Karakioulaki (Basel, Switzerland), L. Grize (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)
| |
Clinical decision making is improved by rapid multiplex-PCR in suspected lower respiratory tract infection after lung transplantation in a prospective cohort study
B. Seeliger (Hannover, Germany), M. Kayser (Hannover, Germany), C. Valtin (Hannover, Germany), J. Fuge (Hannover, Germany), S. Ziesing (Hannover, Germany), T. Welte (Hannover, Germany), M. Pletz (Jena, Germany), P. Chhatwal (Hannover, Germany), J. Gottlieb (Hannover, Germany)
| |
Corticosteroids in severe pneumonia. A propensity score matching study based on real-life.
A. Ceccato (barcelona, Spain), A. Russo (Pisa, Italy), E. Barbeta (Barcelona, Spain), P. Oscanoa (Barcelona, Spain), G. Tiseo (Pisa, Italy), A. Gabarrus (Barcelona, Spain), P. Di Giannatale (Pescara, Italy), S. Nogas (Genoa, Italy), F. Menichetti (Pisa, Italy), M. Ferrer (Barcelona, Spain), M. Falcone (Pisa, Italy), A. Torres (Barcelona, Spain)
| |
Long term clinical outcomes of bronchiectasis in India: Data from the EMBARC/RRNI Indian Bronchiectasis Registry
R. Dhar (West Bengal, India), S. Singh (Jaipur, India), D. Talwar (India, India), M. Mohan (Karnataka, India), S. Tripathi (Utter Pradesh, India), R. Swarnakar (Nagpur, India), S. Trivedi (Chhattisgarh, India), S. Rajagopala (Tamil Nadu, India), G. D'Souza (Karnataka, India), A. Padmanabhan ( Kerala, India), A. Baburao (Karnataka, India), P. Goeminne (Nikolaas, Belgium), M. Crichton (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom), S. Limaye (Pune, India), S. Salvi (Pune, India)
| |
Quality of care in bronchiectasis using the European Respiratory Society Guidelines as a reference standard- data from the EMBARC registry
P. Goeminne (Nikolaas, Belgium), P. Burgel (Paris, France), M. Shteinberg (Haifa, Israel), E. Polverino (Barcelona, Spain), C. Haworth (Cambridge, United Kingdom), M. Loebinger (London, United Kingdom), A. Torres (Barcelona, Spain), O. Sibila (Barcelona, Spain), F. Blasi (Milan, Italy), T. Welte (Hannover, Germany), A. Desoyza (Newcastle, United Kingdom), M. Vendrell (Girona, Spain), F. Ringshausen (Hannover, United Kingdom), A. Shoemark (Dundee (Angus), United Kingdom), A. Hill (Edinburgh, United Kingdom), M. Crichton (Dundee (Angus), United Kingdom), S. Elborn (Belfast, United Kingdom), W. Boersma (Alkmaar, Netherlands), R. Wilson (London, United Kingdom), K. Dimakou (Athens, Greece), J. Chalmers (Dundee (Angus), United Kingdom), S. Aliberti (Milan, Italy)
| |
Deteriorating heath status in bronchiectasis : longitudinal data from the EMBARC registry
S. Aliberti (Milan, Italy), R. Manendez (Valencia, Spain), F. Blasi (Milan, Italy), F. Ringshausen (Hannover, Germany), A. Desoyza (Newcastle, United Kingdom), M. Vendrell (Girona, Spain), P. Goeminne (Nikolaas, Belgium), E. Polverino (Barcelona, Spain), W. Boersma (Alkmaar, Netherlands), P. Burgel (CambridgeParis, France), K. Dimakou (Athens, Greece), C. Haworth (Cambridge, United Kingdom), A. Shoemark (Dundee, United Kingdom), M. Crichton (Dundee, United Kingdom), A. Hill (Edinburgh, United Kingdom), M. Shteinberg (Haifa, Israel), M. Loebinger (London, United Kingdom), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), S. Elborn (Belfast, United Kingdom), J. Chalmers (Dundee, United Kingdom)
| |
RCT Abstract - Fast multiplex bacterial PCR in the bronchoalveolar lavage for antibiotic stewardship in hospitalized patients with pneumonia at risk for Gram negative bacteria infection–the randomized FLAGSHIP II Study
A. Darie (Basel, Switzerland), N. Khanna (Basel, Switzerland), K. Jahn (Basel, Switzerland), M. Osthoff (Basel, Switzerland), S. Basetti (Basel, Switzerland), M. Osthoff (Basel, Switzerland), D. Schumann (Basel, Switzerland), W. Albrich (St. Gallen, Switzerland), M. Brutsche (St. Gallen, Switzerland), L. Grize (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)
| |
Implementation of a Paediatric Bronchiectasis Severity Index (PBSI)
N. Parsons (Birmingham, United Kingdom), P. Kenia (Birmingham, United Kingdom), H. Smith (Birmingham, United Kingdom), P. Nagakumar (Birmingham, United Kingdom)
| |
Discussion
| |
Late Breaking Abstract - The respiratory tract of patients with antibody deficiency on immunoglobulin replacement is characterised by inflammation and dysbiosis despite adequate levels of sputum IgG
A. Schnell (Bern, Switzerland), D. Lowe (London, United Kingdom), S. Graeter (Bern, Switzerland), M. Davrandi (London, United Kingdom), S. Burns (London, United Kingdom), A. Schaub (Bern, Switzerland), M. Saxenhofer (Bern, Switzerland), M. Hauswald (Marburg, Germany), C. Witte (Marburg, Germany), C. Leboreiro (London, United Kingdom), F. Moreira (London, United Kingdom), I. Irincheeva (Bern, Switzerland), I. Schulze (Bern, Switzerland), C. Vonarburg (Bern, Switzerland), A. Feussner (Marburg, Germany)
| |
Immunometabolic markers and the sputum microbiome in bronchiectasis
Y. Giam (Dundee, United Kingdom), H. Richardson (Dundee, United Kingdom), A. Smith (Cambridge, United Kingdom), H. Keir (Dundee, United Kingdom), D. Cassidy (Dundee, United Kingdom), S. Finch (Dundee, United Kingdom), S. Aliberti (Milan, Italy), O. Sibila (Barcelona, Spain), A. Shoemark (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom)
| |
Salivary proinflammatory cytokines and airway bacterial infection in Bronchiectasis
L. Perea Soriano (Barcelona (CT), Spain), R. Faner (Barcelona (CT), Spain), B. Solarat (Barcelona (CT), Spain), A. Agustí (Barcelona (CT), Spain), O. Sibila (Barcelona (CT), Spain)
| |
Inhaled corticosteroids use in patients with bronchiectasis: Data from the EMBARC registry
E. Polverino (Barcelona, Spain), J. Chalmers (Dundee, United Kingdom), S. Aliberti (Milan, Italy), C. Haworth (Cambridge, United Kingdom), F. Blasi (Milan, Italy), W. Boersma (Alkmaar, Netherlands), A. De Soyza (Newcastle, United Kingdom), K. Dimakou (Athens, Greece), S. Elborn (Belfast, United Kingdom), M. Loebinger (London, United Kingdom), A. Torres (Barcelona, Spain), M. Shteinberg (Haifa, Israel), T. Welte (Hannover, Germany), M. Vendrell (Girona, Spain), F. Ringshausen (Hannover, Germany), R. Menendez (Valencia, Spain), A. Shoemark (Dundee, United Kingdom), P. Burgel (Paris, France), P. Goeminne (Nikolaas, Belgium)
| |
Mapping inflammatory endotypes of bronchiectasis associated with impaired mucociliary clearance
M. Bottier (Dundee, United Kingdom), E. Cant (Dundee, United Kingdom), L. Delgado (Dundee, United Kingdom), D. Cassidy (Dundee, United Kingdom), Y. Giam (Dundee, United Kingdom), A. Smith (Dundee, United Kingdom), H. Richardson (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), J. Huang (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), L. Perea (Barcelona, Spain), S. Finch (Dundee, United Kingdom), S. Aliberti (Monza, Italy), O. Sibila (Barcelona, Spain), J. Chalmers (Dundee, United Kingdom), A. Shoemark (Dundee, United Kingdom)
| |
Sputum neutrophil elastase and inhaled antibiotic response in bronchiectasis: a post-hoc analysis of the ORBIT-4 trial
H. Abo-Leyah (Dundee, United Kingdom), H. Richardson (Dundee, United Kingdom), T. Pembridge (Dundee, United Kingdom), Y. Gao (Dundee, United Kingdom), P. Goeminne (Sint-Niklaas, Belgium), C. Haworth (Cambridge, United Kingdom), J. Chalmers (Dundee, United Kingdom)
| |
Changes in sputum bacterial density in people with bronchiectasis: BRONCH UK Study data
Z. Alfahl (Belfast , United Kingdom), G. Einarsson (Belfast, United Kingdom), K. O’Neill (Belfast, United Kingdom), D. F. Gilpin (Belfast, United Kingdom), J. Elborn (Belfast, United Kingdom), K. Ferguson (Belfast, United Kingdom), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London , United Kingdom), M. Carroll (Southampton, United Kingdom), T. Gatheral (Lancaster, United Kingdom), A. De Soyza (Newcastle, United Kingdom), J. Chalmers (Dundee , United Kingdom), C. Johnson (Cambridge , United Kingdom), J. Hurst (London, United Kingdom), J. Brown (London, United Kingdom), J. M. Bradley (Belfast, United Kingdom), M. M. Tunney (Belfast, United Kingdom)
| |
The microbiology of stable bronchiectasis: data from the EMBARC bronchiectasis registry
M. Shteinberg (Haifa, Israel), E. Polverino (Barcelona, Spain), P. Burgel (Paris, France), C. Haworth (Cambridge, United Kingdom), K. Dimakou (Athens, Greece), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London, United Kingdom), R. Menendez (Valenica, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), F. Blasi (Milan, Italy), F. Ringshausen (Hannover, Germany), A. De-Soyza (Newcastle, United Kingdom), M. Vendrell (Girona, Spain), A. Shoemark (Dundee, United Kingdom), W. Boersma (Alkmaar, Netherlands), R. Wilson (London, United Kingdom), J. Chalmers (Dundee, United Kingdom), S. Elborn (Belfast, United Kingdom), S. Aliberti (Milan, Italy), P. Goeminne (Sint-Niklaas, Belgium), J. Altenburg (Amsterdam, Netherlands)
| |
Characterisation of eosinophilic bronchiectasis: A European multicohort study
A. Shoemark (Dundee, United Kingdom), M. Shteinberg (Haifa, Israel), A. De Soyza (Newcastle, United Kingdom), C. Haworth (Cambridge, United Kingdom), H. Richardson (Dundee, United Kingdom), L. Perea (Barcelona, Spain), A. Dicker ( Dundee, United Kingdom), P. Goeminne (Leuven, Belgium), E. Cant (Dundee, United Kingdom), E. Polverino (Barcelona, Spain), J. Altenburg (Amsterdam, Netherlands), H. Keir (Dundee, United Kingdom), M. Loebinger (London, United Kingdom), F. Blasi (Milan, Italy), T. Welte (Hannover, Germany), O. Sibila (Barcelona, Spain), S. Aliberti (Milan, Italy), J. Chalmers (Dundee, United Kingdom)
| |
The bronchiectasis ‘bacteriophagome’
M. Mac Aogáin (Singapore, Singapore), F. Ivan (Singapore, Singapore), T. Jaggi (Singapore, Singapore), H. Keir ( Dundee, Scotland, United Kingdom), A. Dicker ( Dundee, Scotland, United Kingdom), A. Hou (Singapore, Singapore), M. Poh ( Kuala Lumpur, Malaysia), M. Oriano ( Milan, Italy), M. Koh (Singapore, Singapore), O. How (Singapore, Singapore), A. Tee (Singapore, Singapore), T. Low (Singapore, Singapore), J. Abisheganaden (Singapore, Singapore), S. Aliberti ( Milan, Italy), F. Blasi ( Milan, Italy), J. Chalmers ( Dundee, Scotland, United Kingdom), S. Chotirmall (Singapore, Singapore)
| |